$BCDA Balance Sheet | Understand Stock

$BCDA

$0.90 -$0.02 (2.33%) After hours

$BCDA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowance for doubtful accounts of $0 and $0 as of March 31, 2026 and December 31, 2025, respectively
Prepaid expenses
Other receivable due from related party
Total current assets
Property and equipment, net
Operating lease right-of-use asset, net
Other assets
Total assets

Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Operating lease liability - current
Total current liabilities
Operating lease liability - noncurrent
Total liabilities
Stockholders’ equity (deficit):
Preferred stock, $0.001 par value, 25,000,000 shares authorized and no shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.001 par value, 50,000,000 shares authorized, 10,940,372 and 10,755,647 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity (deficit)
Total liabilities and stockholders’ equity (deficit)

Comments